Alpha-1 Antitrypsin Deficiency with Emphysema
Alpha-1 Antitrypsin Deficiency
PMG Research of Wilmington
A research study is evaluating an investigational medication that may slow the progression of alpha-1 antitrypsin deficiency in patients with emphysema.
This research study may be an option if you:
· Have a clinical diagnosis of alpha-1 antitrypsin deficiency
· Have evidence of emphysema
· Have been a non-smoker for at least 12 months
· Have no history of moderate to severe liver fibrosis
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Approximately 5 months
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 9 clinic visits and 2 phone calls